LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.1
 18.98 27.76 1075 941 1.1422 1.0530
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 18.98 27.76 986 941 1.0477 1.0184
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 18.98 27.76 1144 941 1.2155 1.0783
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 20.68 27.76 968 1119 0.8651 0.9464
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 20.68 27.76 1055 1119 0.9428 0.9780
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 20.68 27.76 994 1119 0.8883 0.9561
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 20.68 27.76 1119 1119 1.0000 1.0000
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 22.39 27.76 932 1305 0.7138 0.8822
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 22.39 27.76 999 1305 0.7651 0.9059
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 22.39 27.76 1025 1305 0.7850 0.9147
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 22.39 27.76 1119 1305 0.8570 0.9452
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 24.09 27.76 918 1461 0.6281 0.8438
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 24.09 27.76 975 1461 0.6671 0.8633
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 24.09 27.76 1027 1461 0.7026 0.8803
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 24.09 27.76 1130 1461 0.7731 0.9120
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 25.79 27.76 968 1605 0.6031 0.8345
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 25.79 27.76 1028 1605 0.6404 0.8534
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 25.79 27.76 1064 1605 0.6629 0.8643
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 25.79 27.76 1129 1605 0.7034 0.8833
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 27.49 27.76 974 1723 0.5653 0.8173
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 27.49 27.76 1006 1723 0.5838 0.8272
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 27.49 27.76 1055 1723 0.6123 0.8419
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 27.49 27.76 1101 1723 0.6390 0.8551
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
 29.19 27.76 1000 1863 0.5367 0.8051
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
 29.19 27.76 1038 1863 0.5571 0.8162
MN20160318_Q01
L03